KaraLeanneBickhamMD
Pediatric Infectious Disease • Garrison, NYClinical Director, Vaccine Late Stage Development Merck Research Laboratories
Dr. Bickham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
34 Route 403
Garrison, NY 10524Phone+1 845-424-4444Fax+1 845-424-4664
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1994 - 1997
University of Texas Southwestern Medical SchoolClass of 1994
Certifications & Licensure
NY State Medical License 1997 - 2023
Publications & Presentations
PubMed
- 22 citationsSplenic-priming of virus specific CD8 T cells following influenza virus infectionDamian Turner, Kara L. Bickham, Donna L. Farber, Leo Lefrançois
Journal of Virology. 2013-04-15 - 300 citationsLung niches for the generation and maintenance of tissue-resident memory T cellsDamian Turner, Kara L. Bickham, Joseph J.C. Thome, C. Y. Kim, Frank D'Ovidio
Mucosal Immunology. 2014-05-01 - 625 citationsDistribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell SubsetsTaheri Sathaliyawala, Masaru Kubota, Naomi Yudanin, Damian Turner, Philip Edward Camp
Immunity. 2013-01-24
Press Mentions
- Merck's Vaxneuvance Lead Departs to Help Develop Rival Vaccine at AffinivaxAugust 9th, 2021
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
